These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34819057)

  • 1. Spatial determinants of excess all-cause mortality during the first wave of the COVID-19 epidemic in France.
    Pilkington H; Feuillet T; Rican S; Goupil de Bouillé J; Bouchaud O; Cailhol J; Bihan H; Lombrail P; Julia C
    BMC Public Health; 2021 Nov; 21(1):2157. PubMed ID: 34819057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 mortality with regard to healthcare services availability, health risks, and socio-spatial factors at department level in France: A spatial cross-sectional analysis.
    Tchicaya A; Lorentz N; Leduc K; de Lanchy G
    PLoS One; 2021; 16(9):e0256857. PubMed ID: 34534226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health and healthcare variables associated with Italy's excess mortality during the first wave of the COVID-19 pandemic: An ecological study.
    Buja A; Paganini M; Fusinato R; Cozzolino C; Cocchio S; Scioni M; Rebba V; Baldo V; Boccuzzo G
    Health Policy; 2022 Apr; 126(4):294-301. PubMed ID: 35305852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with the spatial heterogeneity of the first wave of COVID-19 in France: a nationwide geo-epidemiological study.
    Gaudart J; Landier J; Huiart L; Legendre E; Lehot L; Bendiane MK; Chiche L; Petitjean A; Mosnier E; Kirakoya-Samadoulougou F; Demongeot J; Piarroux R; Rebaudet S
    Lancet Public Health; 2021 Apr; 6(4):e222-e231. PubMed ID: 33556327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    COVID-19 Excess Mortality Collaborators
    Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional excess mortality in France during COVID-19 pandemic: the first three epidemic periods (March 2020-June 2021).
    Faisant M; Vincent N; Hubert B; Le Tertre A
    Eur J Public Health; 2024 Jun; 34(3):606-612. PubMed ID: 38390659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess all-cause mortality during the first wave of the COVID-19 epidemic in France, March to May 2020.
    Fouillet A; Pontais I; Caserio-Schönemann C
    Euro Surveill; 2020 Aug; 25(34):. PubMed ID: 32856584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Country-level determinants of the severity of the first global wave of the COVID-19 pandemic: an ecological study.
    Pana TA; Bhattacharya S; Gamble DT; Pasdar Z; Szlachetka WA; Perdomo-Lampignano JA; Ewers KD; McLernon DJ; Myint PK
    BMJ Open; 2021 Feb; 11(2):e042034. PubMed ID: 33536319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographical Variation in Social Determinants of Female Breast Cancer Mortality Across US Counties.
    Anderson T; Herrera D; Mireku F; Barner K; Kokkinakis A; Dao H; Webber A; Merida AD; Gallo T; Pierobon M
    JAMA Netw Open; 2023 Sep; 6(9):e2333618. PubMed ID: 37707814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-cause mortality during the COVID-19 pandemic in Chennai, India: an observational study.
    Lewnard JA; Mahmud A; Narayan T; Wahl B; Selvavinayagam TS; Mohan B C; Laxminarayan R
    Lancet Infect Dis; 2022 Apr; 22(4):463-472. PubMed ID: 34953536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnitude, change over time, demographic characteristics and geographic distribution of excess deaths among nursing home residents during the first wave of COVID-19 in France: a nationwide cohort study.
    Canouï-Poitrine F; Rachas A; Thomas M; Carcaillon-Bentata L; Fontaine R; Gavazzi G; Laurent M; Robine JM
    Age Ageing; 2021 Sep; 50(5):1473-1481. PubMed ID: 33984133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Structural Barriers and Racial Group Disparities of COVID-19 Mortality With Spatial Analysis.
    Lin Q; Paykin S; Halpern D; Martinez-Cardoso A; Kolak M
    JAMA Netw Open; 2022 Mar; 5(3):e220984. PubMed ID: 35244703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in excess all-cause mortality by age, sex, and province during the first wave of the COVID-19 pandemic in Italy.
    Henry NJ; Elagali A; Nguyen M; Chipeta MG; Moore CE
    Sci Rep; 2022 Jan; 12(1):1077. PubMed ID: 35058508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential public healthcare services utilization and excess non-COVID-19 mortality in Greece.
    Kondilis E; Tarantilis F; Benos A
    Public Health; 2021 Sep; 198():85-88. PubMed ID: 34365111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess mortality in England and Wales during the first wave of the COVID-19 pandemic.
    Kontopantelis E; Mamas MA; Deanfield J; Asaria M; Doran T
    J Epidemiol Community Health; 2021 Mar; 75(3):213-223. PubMed ID: 33060194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subnational mortality estimates for India in 2019: a baseline for evaluating excess deaths due to the COVID-19 pandemic.
    Rao C; John AJ; Yadav AK; Siraj M
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34824138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    COVID-19 National Preparedness Collaborators
    Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-scale spatial analysis shows the specular distribution of excess mortality between the first and second wave of the COVID-19 pandemic in Italy.
    Golinelli D; Lenzi J; Adja KYC; Reno C; Sanmarchi F; Fantini MP; Gibertoni D
    Public Health; 2021 May; 194():182-184. PubMed ID: 33962094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
    Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
    BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review.
    Chevance A; Gourion D; Hoertel N; Llorca PM; Thomas P; Bocher R; Moro MR; Laprévote V; Benyamina A; Fossati P; Masson M; Leaune E; Leboyer M; Gaillard R
    Encephale; 2020 Jun; 46(3):193-201. PubMed ID: 32370982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.